Even as MRNA stock plumbs new depths, Moderna's commitment to combat Covid-19 variant strains offers hope of a turnaround. More
Articles
What January’s Activity Means for the Rest of the Year
The "January Barometer" is a solid telltale sign of how the rest of the year will go for Wall Street. So, what did the month tell us? More
5 Things To Expect This Week
While the "January effect" was rather disappointing, February kicks off with an important week ahead for many types of investors. More
Tesla’s Strong Earnings Imply Upside to $1,300 in the Coming Year
TSLA stock should soar over the next two years based on 20% FCF margin estimates of its free cash flow for this year and next year. More
Start Up an AI-Powered Lending Revolution with Upstart
Upstart is improving access to affordable credit -- and UPST stock is surprisingly affordable now, though this opportunity won't last forever. More
Rivian Stock Price Predictions: Did Credit Suisse Really Just Endorse RIVN?
RIVN stock is trading higher in sympathy with a Tesla upgrade and overall market strength. Is the bottom for the EV maker finally in? More
